Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1876-6250

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D ; volume:20 ; number:5 ; day:4 ; month:1 ; year:2012 ; pages:219-228 ; date:5.2012
Netherlands heart journal ; 20, Heft 5 (4.1.2012), 219-228, 5.2012

Creator: Spaendonck-Zwarts, K. Y. van
Kooi, A. J. van der
Berg, M. P. van den
Ippel, E. F.
Boven, L. G.
Yee, W.-C
Wijngaard, A. van den
Brusse, E.
Hoogendijk, J. E.
Doevendans, P. A.
Visser, M. de
Jongbloed, J. D. H.
Tintelen, J. P. van

Contributor: SpringerLink (Online service)

DOI: 10.1007/s12471-011-0233-y

URN: urn:nbn:de:101:1-2019073121325016232828

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Spaendonck-Zwarts, K. Y. van
Kooi, A. J. van der
Berg, M. P. van den
Ippel, E. F.
Boven, L. G.
Yee, W.-C
Wijngaard, A. van den
Brusse, E.
Hoogendijk, J. E.
Doevendans, P. A.
Visser, M. de
Jongbloed, J. D. H.
Tintelen, J. P. van
SpringerLink (Online service)

Other Objects (12)

Founder mutations and genotype-phenotype correlations in Meckel-Gruber syndrome and associated ciliopathies

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations

A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Kapitel

Chapter V. Founder

Islam and its founder

Identification of founder and novel mutations that cause congenital insensitivity to pain (CIP) in palestinian patients

All that glitters is not gold - founder effects complicate associations of flu mutations to disease severity

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

Founder mutations and genotype-phenotype correlations in Meckel-Gruber syndrome and associated ciliopathies

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations

A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Kapitel

Chapter V. Founder

Islam and its founder

Identification of founder and novel mutations that cause congenital insensitivity to pain (CIP) in palestinian patients

All that glitters is not gold - founder effects complicate associations of flu mutations to disease severity

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

Founder mutations and genotype-phenotype correlations in Meckel-Gruber syndrome and associated ciliopathies

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations

A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Kapitel

Chapter V. Founder

Islam and its founder

Identification of founder and novel mutations that cause congenital insensitivity to pain (CIP) in palestinian patients

All that glitters is not gold - founder effects complicate associations of flu mutations to disease severity

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Founder mutations and genotype-phenotype correlations in Meckel-Gruber syndrome and associated ciliopathies

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations

A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Chapter V. Founder

Islam and its founder

Identification of founder and novel mutations that cause congenital insensitivity to pain (CIP) in palestinian patients

All that glitters is not gold - founder effects complicate associations of flu mutations to disease severity

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

Founder mutations and genotype-phenotype correlations in Meckel-Gruber syndrome and associated ciliopathies

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations

A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Chapter V. Founder

Islam and its founder

Identification of founder and novel mutations that cause congenital insensitivity to pain (CIP) in palestinian patients

All that glitters is not gold - founder effects complicate associations of flu mutations to disease severity

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

Founder mutations and genotype-phenotype correlations in Meckel-Gruber syndrome and associated ciliopathies

BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations

A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Chapter V. Founder

Islam and its founder

Identification of founder and novel mutations that cause congenital insensitivity to pain (CIP) in palestinian patients

All that glitters is not gold - founder effects complicate associations of flu mutations to disease severity

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

Related objects

Reset password